EUVIMEDEUVIMED entdecken
Übersichtsarbeit

PNPLA3 variation and kidney disease

Alessandro Mantovani iD, Giovanni Targher iD

Liver International · 2025

DOI: 10.1111/liv.16010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, 2025. Verfasst von Alessandro Mantovani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Vero…. Hauptthemen laut MEDLINE: Membrane Proteins, Lipase, Renal Insufficiency, Chronic, Fatty Liver. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating epidemiological evidence shows that the patatin‐like phospholipase domain‐containing protein‐3 ( PNPLA3 ) rs738409 G allele, which is the most robust genetic variant associated with greater susceptibility to metabolic dysfunction‐associated steatotic liver disease (MASLD), is significantly associated with impaired kidney function in both adults and children, regardless of the presence of common renal risk factors, MASLD severity, and other potential confounders. Although some prospective studies have reported a significant association between the PNPLA3 rs738409 G allele and the increased risk of developing chronic kidney disease (CKD), the epidemiological evidence about a possible direct effect of the PNPLA3 rs738409 G allele on the risk of developing CKD is still limited. Experimentally, PNPLA3 is expressed in renal podocytes, pericytes, and proximal tubule cells, thus supporting the notion that the mutant PNPLA3 protein may play a role in developing renal steatosis and fibrosis. However, it cannot be ruled out that a part of the adverse effect of the PNPLA3 rs738409 G allele on kidney function may be driven by a direct impact of this genetic variant on the development and progression of MASLD. It is possible to hypothesize that identifying the PNPLA3 genotype might help identify individuals at higher risk of CKD and those at greater risk of advanced MASLD. In this narrative minireview, we summarize the current epidemiological data about the association between the PNPLA3 rs738409 G allele and the risk of CKD and abnormal albuminuria. We also briefly discuss the putative biological mechanisms underpinning this association and its potential and future clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsLipaseRenal Insufficiency, ChronicFatty LiverHumansGenetic Predisposition to DiseaseRisk FactorsPolymorphism, Single NucleotideAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

CKDMASLDPNPLA3chronic kidney diseasekidney diseasemetabolic dysfunction‐associated steatohepatitismetabolic dysfunction‐associated steatotic liver diseasepatatin‐like phospholipase domain containing 3

Substanzen

PNPLA3 protein, humanMembrane ProteinsLipaseAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Department of Medicine, University of Verona, Verona, Italy.
  • Metabolic Diseases Research Unit, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Italy.

ORCID-Profile: Alessandro Mantovani, Giovanni Targher

Zitieren

APA

Mantovani, A., & Targher, G. (2025). PNPLA3 variation and kidney disease. Liver International. https://doi.org/10.1111/liv.16010

Vancouver

Mantovani A, Targher G. PNPLA3 variation and kidney disease. Liver International. 2025. doi:10.1111/liv.16010

BibTeX
@article{Mantovani2025,
  author = {Mantovani, Alessandro and Targher, Giovanni},
  title = {PNPLA3 variation and kidney disease},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16010}
}
Kostenlos starten →